October 22-25, 2026 | Boston, USA The World's Foremost Meeting Dedicated to HCM Co-Directors: @MartinMaronMD & @SteveOmmen

Boston, MA
Joined January 2023
Our final Industry Product Theater at #HCM9: New Data on ATTR-CM for Health Care Providers From CARDIO-TTRansform 🗓 Sun, Oct 25 | 1:15–2:15 PM ET | Mezzanine, Level 2 Join an @AstraZeneca- and @ionispharma-sponsored session presenting phase 3 trial results for an investigational treatment for transthyretin amyloid cardiomyopathy (ATTR-CM), with Margaret Cuomo, NP. Open to all Summit registrants. Not part of the accredited program. #ATTRCM
2
3
127
The final morning of #HCM9 (Sun, Oct 25) starts with an Industry Product Theater by #Lexeo Therapeutics. Jennifer White of Lexeo will talk about how Friedreich ataxia cardiomyopathy (FA-CM) often presents with left ventricular hypertrophy that HCM specialists will recognize, but its biology, disease course and unmet needs are very different. This session explores FA-CM and Lexeo’s investigational AAV gene therapy program (LX2006), which is designed to target the root cause of the disease. 📍 Mezzanine & Livestream | 7–8 AM ET | Sun Oct 25 Open to all HCM9 registrants. Not part of the accredited program. #HCM #FriedreichAtaxia #Cardiology
2
4
466
Fabry disease is an under-recognized cause of HCM, and high-risk testing shows it’s more common than we thought. Join @SanofiUS Medical Affairs at #HCM9 for “Two Organs, One Disease: Unifying the Cardio-Renal Approach to Fabry Disease” with @danmassera (NYU Langone) and Ankit Mehta (Baylor Scott & White Health). 🗓 Sat, Oct 24 | 5:45–6:45 PM ET 📍 Seaport Ballroom + livestream + on-demand Industry product theater, open to all HCM9 registrants. Not part of the accredited program. #Fabry
2
2
259
Registered for #HCM9? Start Saturday early with an Product Theater from Amicus Therapeutics: Unmasking a Hidden Diagnosis — HCM and Fabry Disease. Drs. @IacopoOlivotto and Staci Kallish will look at Fabry disease through the lens of the HCM specialist: how it overlaps with and differs from sarcomeric HCM, the diagnostic red flags, and how cardiologists and geneticists can work together to reach a definitive diagnosis. Case studies and live Q&A, moderated by Jason Babby. Sat, Oct 24 | 7:15–8:15a ET | Hot breakfast served Mezzanine | Livestream | On Demand Open to all HCM9 registrants. Not part of the accredited program. #HCMSummit #hypertrophiccardiomyopathy #FabryDisease
2
3
314
Registered for #HCM9? Spend your Saturday lunch hour on a question you see in clinic every week: what does treatment look like for patients with symptomatic oHCM? @Tikuowens walks through the evidence: trial results, safety profile, who’s a good candidate, and the practical part — how to get patients started and keep them on therapy. Bring your questions. Sat, Oct 24 | 12:20–1:20 PM ET (also via livestream) Industry Product Theater presented by @Cytokinetics. Open to all HCM Summit registrants; not part of the accredited program. #hypertrophiccardiomyopathy
1
57
Registered for #HCM9? Join us Fri, Oct 23, in person or via livestream, for an Industry CME Symposium: From Myectomy to Myosin Inhibition — Redefining Disease Modification in HCM. Dr. Carolyn Ho, @mmartinezheart, and @IacopoOlivotto will discuss how the field’s understanding of disease modification has shifted, from surgical relief of obstruction to targeted myosin inhibition. 11:50a–12:50p ET | Mezzanine, Level 2 This activity is supported by an educational grant from Bristol Myers Squibb and is provided by @academiccme. AcademicCME designates this live material for a maximum of 1.0 AMA PRA Category 1 Credit™. #HCMSummit #hypertrophiccardiomyopathy
2
2
423
Kick off Friday at #HCM9 with us and our first morning Industry Product Theater presented by @ImbriaPharma. Join us at 7:15 AM ET in the Mezzanine or via livestream. More details: hcmsummit.org/2026-imbria.
Our first full day at #HCM9 (Fri, Oct 23) starts with an Industry Product Theater presented by #Imbria. Arash Yavari, MBBS, DPhil, Chief Scientific Officer at Imbria, presents "Targeting Cardiac Energetics in Non-obstructive #HCM: From Rationale to Clinical Evidence." Could targeting cardiac energy metabolism improve symptoms and exercise capacity in non-obstructive HCM? This session explores the rationale for ninerafaxstat, an investigational cardiac mitotrope, its published clinical findings and the questions being tested in an ongoing global Phase 2b trial. 📍 Mezzanine & livestream | 7:15–8:15 AM ET Open to all HCM9 registrants. Not part of the accredited program. hcmsummit.org/2026-imbria #HypertrophicCardiomyopathy #Cardiology
3
81
International HCM Summit 9 retweeted
Join @IacopoOlivotto, Dr Carolyn Ho @harvardmed, & me for cutting-edge discussion on #CMIs for #oHCM from @HCMSummit on 23 Oct at 1150 US EDT 1750 CEST. Digital faculty @CMichaelGibson will live-tweet & address your❓from @cardiomet_ce using #HCMyosin. Follow @cardiomet_ce now!
2
9
451
Night one of #HCM9 -- Thu, Oct 22 -- an Industry Product Theater presented by @LexPharma. Join Dr. #SharleneDay, UPenn, as she discusses dual SGLT1 & 2 inhibition in #HCM. (Open to all registrants. Not part of the accredited program.) 📍 Mezzanine, Level 2 | 5:30–6:30 PM ET Learn more: hcmsummit.org/2026-lexicon
To further kick-off #HCM9 on Thu, Oct 22: an Industry Product Theater presented by @LexPharma. Dr. #SharleneDay, UPenn, presents "Beyond the Gradient: Exploring the Potential of Dual SGLT1 & 2 Inhibition in the Treatment of HCM." This product theater will focus on evaluating the mechanism of dual sodium-glucose cotransporter 1 & 2 inhibition as a novel approach to target myocardial energetics and inflammation in patients with hypertrophic cardiomyopathy. An HCM expert will discuss how the dual mechanism may limit oxidative stress and optimize cardiac energy metabolism. 📍 Mezzanine, Level 2 | 🕓 5:30–6:30 PM ET Light refreshments served. Open to all registrants. Not part of accredited program. Learn more: hcmsummit.org/2026-lexicon #HypertrophicCardiomyopathy #Cardiology #HCMSummit #Lexicon #HCM
48
Thank you @EdgewiseTx for this great addition to the #HCM9 weekend line-up. Open to all Summit registrants! #edgewise #hypetrophiccardiomyopathy
Another fantastic Industry Product Theater in our #HCM9 lineup: On Fri 10/23, @EdgewiseTx goes beyond myosin inhibition with investigational sarcomere modulator EDG-7500: MOA, imaging + 12-wk data in nHCM & oHCM. Join @tikuowens, @tabrahammd + Craig Emter, PhD. at 5:40 PM ET. Open to all HCM9 registrants. (Not part of the accredited program.) 🎟️ Not making it to Boston? Virtual tickets remain available through Sun, Oct 25 (with 6 months of on-demand access and full CME credit.) #HCM #hypertrophiccardiomyopathy
1
84
We're officially one month out from #HCM9! 🗓️ Our Summit weekend kicks off Thu, Oct 22 with an Industry Product Theater presented by #BraveheartBio. @DrMarikoHarper1 tackles the topic: "The Future of #HCM Management: Emerging Data and Therapeutic Advances." Despite significant advances in the treatment landscape, managing HCM remains challenging. This session will highlight key considerations in HCM management, review recent developments, and discuss emerging clinical data. 📍 Mezzanine, Level 2 | 🕓 4-5 PM ET | Light refreshments served. Join us! Open to all HCM9 registrants. Not part of the accredited program. Find out more: hcmsummit.org #HCMSummit #HypertrophicCardiomyopathy #Cardiology
60
Boston is full. Virtual isn't. Register today and join us in five weeks — from anywhere in the world. hcmsummit.org/attend #HCMSummit
5 weeks from today, #HCM9 opens in Boston — and the room is officially full. If you didn't get a ticket, we still want you in the room — virtually. Our robust virtual platform gets you full access to every lecture, panel and live Q&A with faculty, plus full CME credit, live-streamed Product Theaters, and on-demand content through next April. Register for virtual today: hcmsummit.org/attend #HCMSummit #hypertrophiccardiomyopathy
1
1
59
Boston isn't the only way into #HCM9 this October. Virtual registration is officially open — bringing full access to every lecture, panel, and live Q&A, plus full CME credit and live-streams of industry Product Theaters. Plus access to all on-demand content through next April. The place to be in HCM—now everywhere you are. Register today at hcmsummit.org/attend. #hypertrophiccardiomyopathy #hcm #hcmsummit
1
5
199
RT @MartinMaronMD: HCM Summit 9 opens with the genetics of the disease. And it closes with the question that the science has been building…
2
5
Back by popular demand — one of HCM8's most talked-about sessions returns this October. #SportsCardiology Register today at hcmsummit.org while tickets last.
One of the most talked-about sessions from the last Summit returns this October in Boston. The guidance on exercise in HCM used to be simple: don't. Not anymore. #BarryMaron, #JamesGuseh & @mmartinezheart trace how sports cardiology evolved — and where the field stands today on competitive eligibility and shared decision-making. Join us Sun, Oct 25 | hcmsummit.org #HCM9 #SportsCardiology #HCM #HypertrophicCardiomyopathy
4
114
50 minutes. No slides. No clock. Just real cases and real reasoning from three of the field's foremost clinicians. Cases with Clinical Masters — Sun, Oct 25 | #HCM9
The HCM cases that don't have a clean answer. This is the HCM Summit at its best. Join @SteveOmmen, @tikuowens & @IacopoOlivotto for a full 50 minutes, no interruptions, discussing real cases, with real reasoning. Special guest moderators @mmartinezheart & @EthanRowin. #HCM9
2
96
A full Sunday dedicated to the questions shaping HCM care today. Don't miss it. #HCM9 hcmsummit.org
Join us Sun, Oct 25 at #HCM9 as we dive into trial endpoints, obesity, pregnancy, & workforce shifts — the questions shaping HCM care right now, not just in the lab, but at the bedside. @steveommen, @noshreza, @carolinecoats, #JorgePlutzky & #AnnaRodonski dig in.
1
116
Is #PFA — pulsed field ablation — really the new gold standard for #AF in #HCM? @konsiont makes the case, then @EthanRowin talks drug therapy, before opening it up for a joint Q&A. Join us Sat, Oct 24, 2026 in Boston for #HCM9.
AF management in #HCM is still evolving fast—and #PFA is at the center of the debate. Saturday at #HCM9, @konsiont makes the case for pulsed field ablation as the new gold standard; @EthanRowin makes the case for drug therapy. Then it's open floor—bring your questions. #AFib
162
One of the toughest challenges in #HCM care, tackled by an incredible faculty. See you Sat 10/24. #HCM9 Register today at hcmsummit.org.
Nonobstructive HCM remains one of the field's biggest open questions. On Sat 10/24, @MKittlesonMD, @tikuowens, #SharleneDay, @AWangDukeU and I dig into why symptoms persist, what #CMIs taught us, and what's next: SONATA-HCM, FORTITUDE-HCM, and targeting outside the myosin. #HCM9
1
1
88